MedTrace Logo

The Experience of TYAC Offered Ovarian Tissue Cryopreservation

NCT02830061 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2019-10-24

No results posted yet for this study

Summary

This study looks at the experiences of teenagers and young adults who have been offered ovarian tissue cryopreservation prior to cancer treatment as a result of their cancer and/or cancer treatment putting them at moderate-to-high risk of premature ovarian failure.

Conditions

Interventions

OTHER

Interviews

Individual semi-structured interviews for 30-60 minutes using an interview schedule developed from an interpretative phenomenological analysis framework.

Sponsors & Collaborators

  • Oxford University Hospitals NHS Trust

    collaborator OTHER

  • University of Oxford

    lead OTHER

Principal Investigators

  • Rebekah Tennyson, DClinPsy · Oxford Health NHS Foundation Trust

Eligibility

Min Age
13 Years
Max Age
25 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2018-07-31
Completion
2018-09-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02830061 on ClinicalTrials.gov